Trial completion date • Trial primary completion date
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
ER positive • HER-2 negative • ER positive + HER-2 negative
|
cisplatin • carboplatin • albumin-bound paclitaxel • AiRuiKang (dalpiciclib) • adebrelimab (SHR-1316)